Woodline Partners LP Celldex Therapeutics, Inc. Transaction History
Woodline Partners LP
- $11 Billion
- Q3 2024
A detailed history of Woodline Partners LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 2,341,121 shares of CLDX stock, worth $61.8 Million. This represents 0.72% of its overall portfolio holdings.
Number of Shares
2,341,121
Previous 757,771
208.95%
Holding current value
$61.8 Million
Previous $28 Million
183.57%
% of portfolio
0.72%
Previous 0.28%
Shares
10 transactions
Others Institutions Holding CLDX
# of Institutions
207Shares Held
67.3MCall Options Held
1.69MPut Options Held
980K-
Wellington Management Group LLP Boston, MA9.24MShares$244 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$124 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.87MShares$102 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.46MShares$91.3 Million9.64% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$88 Million1.99% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.23B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...